Page last updated: 2024-11-04

sulforaphane and Hemorrhage, Subarachnoid

sulforaphane has been researched along with Hemorrhage, Subarachnoid in 2 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zolnourian, AH1
Franklin, S1
Galea, I1
Bulters, DO1
Zhao, X1
Wen, L1
Dong, M1
Lu, X1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
SFX-01 After Subarachnoid Haemorrhage[NCT02614742]Phase 290 participants (Actual)Interventional2016-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for sulforaphane and Hemorrhage, Subarachnoid

ArticleYear
Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial.
    BMJ open, 2020, 03-25, Volume: 10, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; alpha-Cyclodextrins; Cardiovascula

2020

Other Studies

1 other study available for sulforaphane and Hemorrhage, Subarachnoid

ArticleYear
Sulforaphane activates the cerebral vascular Nrf2-ARE pathway and suppresses inflammation to attenuate cerebral vasospasm in rat with subarachnoid hemorrhage.
    Brain research, 2016, 12-15, Volume: 1653

    Topics: Animals; Appetite; Basilar Artery; Carboxylic Ester Hydrolases; Cytokines; Disease Models, Animal; D

2016